Russian President Vladimir Putin made the announcement on Wednesday, during a televised meeting with government officials. The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia and tested on 100 volunteers. Russia plans to manufacture an initial 10000 doses, Vektor said, with production expected to begin in November.
Russia’s first vaccine, Sputnik V, was developed by the Gamaleya Institute in Moscow and approved by the government in August.
According to Russia’s Health Ministry, about 400 high-risk patients have received the Sputnik V vaccine.
- Key things about Russia’s second COVID-19 vaccine EpiVacCorona
- President Putin says Russia is ‘first’ to develop coronavirus vaccine
- Russian President confirms Sputnik V COVID-19 vaccine as effective and safe
- Russia ready to approve 2nd COVID-19 vaccine
- Russia names its first COVID-19 vaccine ‘Sputnik V’
- Russia s COVID 19 vaccine pre ordered by 20 nations for a billion doses
- Russia’s COVID-19 vaccine pre-ordered by 20 nations for a billion doses
- Covid 19 vaccine update Controversial Russia s Sputnik V and its availability
- Russia to begin COVID-19 vaccine production in November
- Covid-19 vaccine update: Controversial Russia’s ‘Sputnik V’ and its availability